DrugPatentWatch Database Preview
PRILOSEC OTC Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Prilosec Otc, and what generic alternatives are available?
This drug has forty-eight patent family members in nineteen countries.
The generic ingredient in PRILOSEC OTC is omeprazole magnesium. There are one hundred and twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the omeprazole magnesium profile page.
Summary for PRILOSEC OTC
| International Patents: | 48 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 161 |
| Clinical Trials: | 21 |
| Patent Applications: | 4,117 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for PRILOSEC OTC |
| DailyMed Link: | PRILOSEC OTC at DailyMed |
Synonyms for PRILOSEC OTC
| ( -)-Omeprazole |
| (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole |
| (.+/-.)-Omeprazole |
| (+-)-Omeprazole |
| (+)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole |
| (+)-omeprazole |
| (omeprazole)5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole |
| (R)-Esomeprazole |
| (RS)-5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridylmethylsulphinyl)benzimidazole |
| (RS)-6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d]imidazole |
| (s)-omeprazole sodium |
| (S)-Omeprazole sodium salt hydrate |
| 119141-88-7 (base) |
| 131959-78-9 |
| 141O887 |
| 161796-78-7 |
| 161973-10-0 |
| 172964-80-6 |
| 177541-02-5 |
| 1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)- |
| 1H-Benzimidazole, 6-methoxy-2-((R)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)- |
| 1H-BENZIMIDAZOLE,6-METHOXY-2-[(R)-[(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]- |
| 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole |
| 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole |
| 2-(3-methoxy-2,4-dimethylbenzylsulfinyl)-6-methoxy-1H-benzo[d]imidazole |
| 2,3,5-Trimethylpyridine/Omeprazole |
| 217087-09-7 |
| 3B1-000638 |
| 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyrdinyl)-methyl]sulfinyl]-1H-benzimidazole |
| 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole |
| 5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole |
| 5-methoxy-1H-1,3-benzimidazol-2-yl (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl sulfoxide |
| 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole |
| 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, magnesium salt (2:1) |
| 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
| 5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole |
| 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)- |
| 5-methoxy-2-(2-(4-methoxy-3,5-dimethylpyridin-2-yl)ethylsulfinyl)-1H-benzo[d]imidazole |
| 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole |
| 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole (omeprazole) |
| 5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole(Omeprazole) |
| 5-methoxy-2-[ methylsulfinyl]-3H-benzoimidazole |
| 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1H-benzimidazole |
| 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole |
| 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3H-benzoimidazole |
| 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole |
| 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-3H-1,3-benzodiazole |
| 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole |
| 5-Methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole |
| 5-methoxy-2-[[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole |
| 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole |
| 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; Antra; Losec |
| 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole |
| 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-benzimidazole |
| 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfonyl]benzimidazole |
| 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]1H-benzimidazole |
| 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole |
| 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole |
| 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole |
| 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole |
| 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole |
| 6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole |
| 6-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole |
| 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole |
| 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole |
| 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt |
| 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole |
| 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole |
| 6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole |
| 6-methoxy-2-[[(4-methoxy3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole |
| 6-methoxy-2-[[(4methoxy-3,5-dimethyl2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole |
| 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole |
| 668985-31-7 (Mg) |
| 73590-58-6 |
| 95382-33-5 |
| A19447 |
| A810316 |
| A837865 |
| AB0014122 |
| AB1009257 |
| AB2000267 |
| AC-401 |
| AC-4676 |
| AC1L1IIJ |
| AC1L2XM7 |
| AC1NSJYQ |
| ACMC-20p1du |
| AGI-010 |
| AK162396 |
| AKOS005066653 |
| AKOS015895343 |
| AKOS015896379 |
| AKOS025402081 |
| AN-11759 |
| AN-11885 |
| AN-15878 |
| AN-34918 |
| Antra |
| Antra MUPS |
| Audazol |
| AULCER |
| azol-1-ide |
| BBL028172 |
| BC203197 |
| BC226373 |
| BDBM50103597 |
| BDBM50241343 |
| Belmazol |
| BIDD:GT0189 |
| Bio-0888 |
| BPBio1_000425 |
| BRD-A55962179-001-04-9 |
| BSPBio_000385 |
| C07324 |
| C17H19N3O3S |
| CAS-73590-58-6 |
| CCG-101130 |
| CCG-213517 |
| CCRIS 7099 |
| CE0112 |
| Ceprandal |
| CHEBI:77260 |
| CHEBI:91766 |
| CHEBI:94401 |
| CHEMBL1503 |
| CHEMBL1567328 |
| cid_4594 |
| CO0037 |
| CPD000058847 |
| CS-1868 |
| CTK8E8954 |
| CTK8I2124 |
| CTK9A5793 |
| D00455 |
| D01XNB |
| D05259 |
| Danlox |
| DB00338 |
| Demeprazol |
| Desec |
| Dizprazol |
| DL-462 |
| DM-3458 |
| DR001724 |
| DSSTox_CID_1080 |
| DSSTox_GSID_21080 |
| DSSTox_RID_75929 |
| DTXSID6021080 |
| Dudencer |
| Elgam |
| Emeproton |
| Emilok |
| Epirazole |
| Erbolin |
| Esomeprazole |
| Esomeprazole magnesium |
| Esomeprazole magnesium trihydrate |
| ESOMEPRAZOLE Mg |
| Esomeprazole Sodium |
| Esomeprazole sodium salt |
| Esomeprazole sodium salt hydrate |
| Esomeprazole(magnesium) |
| Esomperazole |
| Exter |
| F0001-2386 |
| FT-0601585 |
| FT-0652860 |
| FT-0653294 |
| FT-0657297 |
| Gasec |
| Gastrimut |
| Gastrogard |
| Gastroloc |
| Gibancer |
| GTPL4279 |
| H 168-68 |
| H 168/68 |
| H 168/68 magnesium |
| H-168/68 |
| H168/68 |
| HE073137 |
| HE226602 |
| HE316079 |
| HE340315 |
| HE417571 |
| HMS1528I05 |
| HMS1569D07 |
| HMS2052G17 |
| HMS2090E16 |
| HMS2090F11 |
| HMS2096D07 |
| HMS2232B21 |
| HMS2878H13 |
| HMS3269D17 |
| HMS3394G17 |
| HMS3651A11 |
| HS-0055 |
| HSDB 3575 |
| HY-B0113 |
| I06-0705 |
| I06-1976 |
| I14-40975 |
| IDI1_032523 |
| Indurgan |
| Inhibitron |
| Inhipump |
| J-014249 |
| J10125 |
| K253 |
| KB-63582 |
| KS-000001KH |
| KWORUUGOSLYAGD-UHFFFAOYSA-N |
| Lensor |
| Logastric |
| Lomac |
| Losec |
| Losec (TN) |
| Losec, Omesec, Prilosec, Zegerid, Omeprazole |
| LS-7629 |
| magnesium 5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide 6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imid |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
| magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
| magnesium(2+) bis(5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazol-1-ide) |
| MAGNESIUM(2+) ION 5-METHOXY-2-[(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHANESULFINYL]-1H-1,3-BENZODIAZOL-1-IDE 6-METHOXY-2-[(4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL)METHANESULFINYL]-1H-1,3-BENZODIAZOL-1-IDE |
| Maybridge4_002645 |
| MCULE-3224208952 |
| Mepral |
| MFCD00083192 |
| MFCD06798050 |
| Miol |
| Miracid |
| MLS000069373 |
| MLS001076112 |
| MLS001165732 |
| MLS001424148 |
| MLS006010400 |
| MLS006011759 |
| MolPort-003-666-741 |
| MolPort-003-849-702 |
| MolPort-016-633-260 |
| Mopral |
| Morecon |
| NC00380 |
| NCGC00016925-01 |
| NCGC00016925-02 |
| NCGC00016925-03 |
| NCGC00016925-04 |
| NCGC00016925-05 |
| NCGC00016925-06 |
| NCGC00016925-07 |
| NCGC00016925-08 |
| NCGC00016925-10 |
| NCGC00016925-11 |
| NCGC00021522-03 |
| NCGC00021522-04 |
| NCGC00021522-05 |
| NCGC00258063-01 |
| NE55490 |
| Nexiam |
| Nexium |
| Nexium IV |
| Nilsec |
| Nopramin |
| NSC-751450 |
| NSC-759192 |
| NSC751450 |
| NSC759192 |
| Nuclosina |
| O0359 |
| Ocid |
| Olexin |
| Olit |
| Omapren |
| Omebeta |
| Omebeta 20 |
| Omed |
| Omegast |
| OMEP |
| Omepradex |
| Omepral |
| Omeprazen |
| Omeprazol |
| Omeprazol [INN-Spanish] |
| omeprazole |
| Omeprazole (JAN/USP/INN) |
| Omeprazole (JP17/USP/INN) |
| Omeprazole (Prilosec) |
| Omeprazole [USAN:INN:BAN:JAN] |
| Omeprazole [USAN:USP:INN:BAN:JAN] |
| Omeprazole delayed-release |
| Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Omeprazole magnesium |
| omeprazole magnesium (10 mg) |
| Omeprazole magnesium (USAN) |
| Omeprazole magnesium [USAN:USP] |
| Omeprazole magnesium [USAN] |
| omeprazole magnesium, ep |
| omeprazole mg |
| Omeprazole Pellets |
| OMEPRAZOLE SODIUM |
| omeprazole sodium bicarbonate |
| Omeprazole solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
| Omeprazole, (R)- |
| Omeprazole, 98% 1g |
| Omeprazole, analytical reference material |
| Omeprazole, European Pharmacopoeia (EP) Reference Standard |
| Omeprazole, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Omeprazole, solid |
| Omeprazole, United States Pharmacopeia (USP) Reference Standard |
| Omeprazolum |
| Omeprazolum [INN-Latin] |
| Omeprazon |
| Omeprazone |
| Omeprol |
| Omerprazole |
| Omesec |
| Omesek |
| Omez |
| Omezol |
| Omezolan |
| Omid |
| Omisec |
| Omizac |
| Ompanyt |
| Omperazole |
| OMZ |
| Opera_ID_1863 |
| Ortanol |
| Osiren |
| Ozoken |
| Paprazol |
| Parizac |
| Pepticum |
| Pepticus |
| Peptilcer |
| Pharmakon1600-01505693 |
| Prazentol |
| Prazidec |
| Prazolit |
| Prestwick_808 |
| Prestwick0_000493 |
| Prestwick1_000493 |
| Prestwick2_000493 |
| Prestwick3_000493 |
| Prilosec |
| Prilosec (TN) |
| Prilosec OTC (TN) |
| Procelac |
| Proclor |
| Prysma |
| Q-100195 |
| r-omeprazole |
| R-Omeprazole [USP-RS] |
| Ramezol |
| Regulacid |
| Result |
| RT-012496 |
| s1389 |
| S51HU491WJ |
| SAM001246900 |
| SAN-15 |
| Sanamidol |
| SBI-0206896.P001 |
| SC-15162 |
| SC-72064 |
| SCHEMBL1191 |
| SCHEMBL11995456 |
| SCHEMBL722792 |
| Secrepina |
| SMR000058847 |
| SMR000550477 |
| SPBio_002306 |
| ST24048844 |
| ST51053319 |
| STK623746 |
| SUBDBMMJDZJVOS-UHFFFAOYSA-N |
| Tedec Ulceral |
| TL8005099 |
| Tox21_110686 |
| Tox21_110686_1 |
| Tox21_200509 |
| Ulceral |
| Ulcesep |
| Ulcometion |
| Ulcozol |
| Ulcsep |
| Ulsen |
| Ultop |
| Ulzol |
| UNII-426QFE7XLK |
| UNII-S51HU491WJ |
| UPCMLD-DP075 |
| UPCMLD-DP075:001 |
| Victrix |
| Z1672902589 |
| Zefxon |
| Zegerid |
| Zepral |
| Zimor |
| Zoltum |
US Patents and Regulatory Information for PRILOSEC OTC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharms | PRILOSEC OTC | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 021229-001 | Jun 20, 2003 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Astrazeneca Pharms | PRILOSEC OTC | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 021229-001 | Jun 20, 2003 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Expired US Patents for PRILOSEC OTC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Astrazeneca Pharms | PRILOSEC OTC | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 021229-001 | Jun 20, 2003 | ➤ Sign Up | ➤ Sign Up |
| Astrazeneca Pharms | PRILOSEC OTC | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 021229-001 | Jun 20, 2003 | ➤ Sign Up | ➤ Sign Up |
| Astrazeneca Pharms | PRILOSEC OTC | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 021229-001 | Jun 20, 2003 | ➤ Sign Up | ➤ Sign Up |
| Astrazeneca Pharms | PRILOSEC OTC | omeprazole magnesium | TABLET, DELAYED RELEASE;ORAL | 021229-001 | Jun 20, 2003 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for PRILOSEC OTC
| Drugname | Dosage | Strength | RLD | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2012-03-30 |
| ➤ Subscribe | Delayed-release Capsules | 20 mg | ➤ Subscribe | 2007-03-19 |
see a sample report or, see our see our flat-rate plans
International Patents for PRILOSEC OTC
Supplementary Protection Certificates for PRILOSEC OTC
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 12/048 | Ireland | ➤ Sign Up | PRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812 |
| 11/016 | Ireland | ➤ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
| C/GB11/015 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| C/GB11/013 | United Kingdom | ➤ Sign Up | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
